Results 51 to 60 of about 52,279 (251)

Estimating global prevalence of gallbladder stones in general population from 2000 to 2024: systematic review and meta-analysis

open access: yesAnnals of Medicine
Background Gallbladder stones (GS), is one of the most common and costly of all the gastrointestinal diseases. However, global prevalence estimates of GS remain heterogeneous due to methodological variations across studies, and consensus on risk factor ...
Qingyang Ning   +5 more
doaj   +1 more source

Parathyroid hemangioma

open access: yesAutopsy and Case Reports, 2021
Background: Hemangiomas are benign neoplasms of capillary proliferation that arise from a developmental anomaly where angioblastic mesenchyme fails to form canals.
Odille Mejia   +4 more
doaj  

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay   +5 more
wiley   +1 more source

Cyclin D1 in parathyroid disease [PDF]

open access: yesFrontiers in Bioscience, 2000
Primary hyperparathyroidism (HPT), most commonly due to parathyroid adenoma, is a disorder characterized by excessive secretion of PTH. So far, abnormalities in two genes, cyclin D1 and MEN1, have been implicated in the development of parathyroid adenomas.
S M, Mallya, A, Arnold
openaire   +2 more sources

Are non-coding rnas useful biomarkers in parathyroid tumorigenesis? [PDF]

open access: yes, 2021
Tumors of the parathyroid glands are common endocrine diseases almost always characterized by parathyroid hormone hypersecretion that determines the clinical manifestations of primary hyperparathyroidism, such as fatigue, kidney problems, weakness ...
Cinzia Aurilia   +11 more
core   +1 more source

Clinical suspicion and parathyroid carcinoma management

open access: yesSão Paulo Medical Journal
CONTEXT AND OBJECTIVE: Adequate management of parathyroid carcinoma apparently relates to the surgeon’s ability to identify it at the first operation.
Fabio Luiz de Menezes Montenegro   +5 more
doaj   +1 more source

Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Discontinuation of denosumab (Dmab) may be necessary due to adverse events or an unfavorable long‐term risk–benefit profile. However, accumulating evidence demonstrates pronounced rebound phenomena after withdrawal, most notably a marked increase in multiple vertebral fractures, and, in some reports, elevated mortality.
Ko‐Hsiu Lu   +5 more
wiley   +1 more source

Secretopathies emerge as a new class of neurocristopathies

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Neural crest cells are a transient embryonic population of cells that give rise to a wide range of structures, including craniofacial cartilage and bone, peripheral neurons and glia, as well as components of the cardiac outflow tract, among others.
Amanda Teixeira   +3 more
wiley   +1 more source

Nonfunctional parathyroid cyst: case report

open access: yesSão Paulo Medical Journal
CONTEXT: Parathyroid cysts are rare clinical and pathological entities, with less than 300 cases reported. The inferior parathyroid glands are most commonly involved, with left-side predominance.
Carlos Eduardo Molinari Nardi   +3 more
doaj   +1 more source

Recurrence hyperparathyroidism caused by synchronous parathyroid carcinoma and parathyromatosis in a patient with long-term hemodialysis

open access: yesBMC Nephrology, 2023
Background Parathyroid carcinoma and parathyromatosis are very rare diseases in patients on hemodialysis. Its pathogenesis, clinical features, preoperative diagnosis, and surgery are challenging.
Jun Yang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy